Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

HTBX Quote, Trading Chart, Heat Biologics Inc.


home / stock / htbx / htbx quote

$7.87 Last:

-3.91% Change Percent:

$8.22 Open:

$7.87 Previous Close:

$8.35 High:

$7.72 Low:

630,191 Volume:

03/02/2021 04:55:32 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-03-028.227.878.357.72630,191
2021-03-018.118.198.377.921,002,168
2021-02-267.987.988.137.56709,497
2021-02-258.47.918.6057.761,014,191
2021-02-248.378.468.938.31848,588
2021-02-238.648.338.687.81,371,859
2021-02-229.459.059.64998.911,013,450
2021-02-199.429.69.829.3601857,129
2021-02-189.819.31109.231,051,638
2021-02-1710.4210.110.429.41,975,531
2021-02-1611.4310.6911.5510.51012,749,961
2021-02-1511.411.4312.4611.051,673,311
2021-02-1211.411.4312.4611.051,661,631
2021-02-1111.2811.8412.2810.853,449,229
2021-02-1012.8311.0112.9110.216,819,494
2021-02-0916.9912.541711.5170,278,167
2021-02-087.51248.378.477.41,913,264
2021-02-057.787.547.817.181,262,403
2021-02-047.517.617.847.311,422,482
2021-02-037.23427.467.57.0575970,757
Stock Information

Heat Biologics Inc. Company Name:

HTBX Stock Symbol:

NASDAQ Market:

Heat Biologics Inc. Website:

HTBX Quote, Trading Chart, Heat Biologics Inc.

MENU
HTBX HTBX Quote HTBX Short HTBX News HTBX Articles HTBX Message Board
Get HTBX Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT HTBX NEWS
  • HTBX - Heat Biologics to Present at 2021 BIO CEO & Investor Digital Conference

    DURHAM, NC / ACCESSWIRE / February 12, 2021 / Heat Biologics, Inc. ("Heat") (Nasdaq:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, ...

  • HTBX - Heat Biologics Announces Positive Interim Survival Data from Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial

    Median overall survival of 24.6 months in previously treated checkpoint inhibitor naïve non-small cell lung cancer patients who received HS-110 in combination with nivolumab DURHAM, NC / ACCESSWIRE / February 9, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-sta...

  • HTBX - Heat Biologics Announces Publication of Additional Preclinical COVID-19 Vaccine Results

    Spike specific CD8+ and CD4+ T-cell memory responses observed 30- and 60- days post vaccination DURHAM, NC / ACCESSWIRE / January 27, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to mod...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News